This paper is in the following e-collection/theme issue:

Clinical Information and Decision Making (1371) Secondary Use of Clinical Data for Research and Surveillance (349) Outbreak and Pandemic Preparedness and Management (1706) Tools, Programs and Algorithms (260) Health Services Research (435)

Published on in Vol 26 (2024)

This is a member publication of University of Oxford (Jisc)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/56042, first published .
Creating a Modified Version of the Cambridge Multimorbidity Score to Predict Mortality in People Older Than 16 Years: Model Development and Validation

Creating a Modified Version of the Cambridge Multimorbidity Score to Predict Mortality in People Older Than 16 Years: Model Development and Validation

Creating a Modified Version of the Cambridge Multimorbidity Score to Predict Mortality in People Older Than 16 Years: Model Development and Validation

Authors of this article:

Debasish Kar1, 2 Author Orcid Image ;   Kathryn S Taylor1 Author Orcid Image ;   Mark Joy1 Author Orcid Image ;   Sudhir Venkatesan3 Author Orcid Image ;   Wilhelmine Meeraus4 Author Orcid Image ;   Sylvia Taylor4 Author Orcid Image ;   Sneha N Anand1 Author Orcid Image ;   Filipa Ferreira1 Author Orcid Image ;   Gavin Jamie1 Author Orcid Image ;   Xuejuan Fan1 Author Orcid Image ;   Simon de Lusignan1, 5 Author Orcid Image
Article Authors Cited by Tweetations Metrics

Debasish Kar   1, 2 * , MD, FRCP ;   Kathryn S Taylor   1 * , PhD ;   Mark Joy   1 , PhD ;   Sudhir Venkatesan   3 , PhD ;   Wilhelmine Meeraus   4 , PhD ;   Sylvia Taylor   4 , PhD ;   Sneha N Anand   1 , PhD ;   Filipa Ferreira   1 , PhD ;   Gavin Jamie   1 , MSc, MBBS ;   Xuejuan Fan   1 , PhD ;   Simon de Lusignan   1, 5 , MBBS

1 Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom

2 Peninsula Medical School, University of Plymouth, Plymouth, United Kingdom

3 Medical & Payer Evidence Statistics, BioPharmaceuticals Medical, AstraZeneca PLC, Cambridge, United Kingdom

4 Medical Evidence, Vaccines and Immune Therapies, AstraZeneca PLC, Cambridge, United Kingdom

5 Royal College of General Practitioners of the United Kingdom, London, United Kingdom

*these authors contributed equally

Corresponding Author:

  • Kathryn S Taylor, PhD
  • Nuffield Department of Primary Care Health Sciences
  • University of Oxford
  • Radcliffe Primary Care Building, Radcliffe Observatory Quarter
  • Woodstock Road
  • Oxford, OX2 6GG
  • United Kingdom
  • Phone: 44 1865617855
  • Email: kathryn.taylor@phc.ox.ac.uk